|
⚲
|
| Keyboard |
| Cheng Isaac
✚
|
|
|---|---|
| CIK # | 0001829696 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001829696] | |
| 4 | [0001829696] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Amylyx Pharmaceuticals Inc | |
| Cheng Isaac | |
| Atea Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Amylyx Pharmaceuticals Inc AMLX
Stock Option (Right to Buy) · derivative
|
2022-06-09 | Grant | 19,000 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-01-06 | Conversion | 6,410,964 | ||
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-01-06 | Conversion | 974,107 | ||
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-01-06 | Conversion | 1,621,544 | ||
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-01-06 | Buy | 6,578 | $19.00 | 124,982 |
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-01-06 | Conversion | 1,409,035 | ||
|
Amylyx Pharmaceuticals Inc AMLX
Series C-1 Preferred Stock · derivative
|
2022-01-06 | Conversion | 974,107 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Series B Preferred Stock · derivative
|
2022-01-06 | Conversion | 6,410,964 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Series A Preferred Stock · derivative
|
2022-01-06 | Conversion | 1,409,035 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Stock Option (Right to Buy) · derivative
|
2022-01-06 | Grant | 8,400 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Series C-2 Preferred Stock · derivative
|
2022-01-06 | Conversion | 1,621,544 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2020-10-29 | Grant | 80,000 | $0.00 |